Comerica Bank’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Comerica Bank’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-700	Closed	-$27.2K	–	3801
2025 Q3	$27.2K	Buy	+700	New	+$24.1K	﹤0.01%	3034
2025 Q2	–	Sell	-810	Closed	-$23.1K	–	3789
2025 Q1	$23.1K	Hold	810	–	–	﹤0.01%	2990
2024 Q4	$26.8K	Hold	810	–	–	﹤0.01%	2962
2024 Q3	$30.2K	Hold	810	–	–	﹤0.01%	2923
2024 Q2	$27.2K	Sell	810 -220	-21%	-$7.37K	﹤0.01%	2916
2024 Q1	$36.8K	Buy	1,030 +220	+27%	+$7.62K	﹤0.01%	2844
2023 Q4	$26.7K	Sell	810 -1,354	-63%	-$36.4K	﹤0.01%	2898
2023 Q3	$58.9K	Buy	+2,164	New	+$65.2K	﹤0.01%	2660

Other funds holding SBIO

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

DIM

Delta Investment Management San Francisco, California $608M AUM 25.3% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.28B AUM 22.9% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Comerica Bank's SBIO Position: Q4 2025 in Review

Comerica Bank sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2025, closing a stake of 700 shares — an estimated $27.2K sold.

Comerica Bank first reported a position in SBIO in Q3 2023 and held it in 8 quarters. The position peaked at $58.9K in Q3 2023. 59 funds tracked by Wall St. Rank hold SBIO as of Q4 2025.

Comerica Bank reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2025 after selling out during the quarter.
Comerica Bank sold 700 ALPS Medical Breakthroughs ETF shares in Q4 2025, an estimated $27.2K.
Comerica Bank first reported a position in ALPS Medical Breakthroughs ETF in Q3 2023 and held it in 8 quarters.
Comerica Bank's ALPS Medical Breakthroughs ETF position peaked at $58.9K in Q3 2023.
59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.